Bayés, B <br/><br/>
Do anti-CD25 monoclonal antibodies potentiate posttransplant diabetes mellitus?  [electronic resource] 

 -  Transplantation proceedings  Sep 2007 
 - 2248-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2007.06.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antigens, CD--immunology<br/>Basiliximab<br/>Body Mass Index<br/>Body Weight<br/>Diabetes Mellitus--immunology<br/>Female<br/>Graft Rejection--epidemiology<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Interleukin-2 Receptor alpha Subunit--immunology<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Postoperative Complications--immunology<br/>Recombinant Fusion Proteins--adverse effects